HOME >> BIOLOGY >> NEWS
University of Pittsburgh receives $10 million grant for head and neck cancer

PITTSBURGH, Aug. 26 The University of Pittsburgh Cancer Institute (UPCI) has received a five-year, $10 million Specialized Program of Research Excellence (SPORE) federal grant to examine innovative treatment strategies designed to improve survival outcomes for patients with head and neck cancer. The grant, awarded by the National Cancer Institute (NCI), is the second SPORE awarded to UPCI the first was awarded to the cancer institute's Lung Cancer Program in 2001 and is one of only four SPORE grants in head and neck cancer awarded nationally.

"Head and neck cancer is one of the most physically and emotionally debilitating cancers," said Jennifer Grandis, M.D., principal investigator of the grant and professor of otolaryngology and pharmacology, University of Pittsburgh School of Medicine, and director of UPCI's Head and Neck Cancer Program. "Treatment options are limited and often leave a patient with disabling side effects that can have a devastating impact on quality of life. This grant will enable us to enhance the quality of life for head and neck cancer patients and greatly improve their prognoses through the collaborative efforts of our researchers in the laboratory and clinic."

The grant funds four major translational research projects that focus on genetic changes that are potential risk factors for head and neck cancer, intracellular signaling proteins activated during head and neck cancer, and new treatment strategies designed to reduce the morbidity and mortality from head and neck cancer.

According to Dr. Grandis, each project within the grant has two co-leaders, one with expertise in basic or laboratory science and the other with expertise in clinical research and care. By integrating laboratory findings with clinical research and epidemiological data, Dr. Grandis expects study results to be more rapidly disseminated to cancer patients. The grant also includes input from patient advocates who will focus on research-related
'"/>


26-Aug-2004


Page: 1 2 3

Related biology news :

1. Indiana University, EPA to study airborne PCBs
2. University of Alberta researcher looks for clues to mysterious disease
3. Northeastern University receives $12.4 million NSF grant for creation of nanomanufacturing institute
4. Washington University in St. Louis leads group studying aging process
5. Tufts University establishes $4 million dollar tissue engineering resource center
6. Case for IBD combination therapy comes from research at Baylor, MIT and Hebrew University
7. As informatics grows, Indiana University helps set research agenda
8. University of Arizona licenses patent for natural fungicide
9. Washington University in St. Louis plays key role in sequencing moss genome
10. Clemson University spin-off uses corn to make plastics, provide cleaner air
11. Carnegie Mellon University hosts ACS-PRF summer school on green chemistry

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/9/2019)... ... July 08, 2019 , ... On June ... ownership of the innovation behind two Danisco amylase patent applications (EP2859097 and EP2825643). ... based on prior art was without merit and awarded costs to Danisco. ...
(Date:6/20/2019)... Fla. (PRWEB) , ... June 19, 2019 , ... ... recently announced by the Infectious Diseases Society of America Foundation, and the possibly ... on Aging to study infectious agents in AD, are a “welcome affirmation” of ...
(Date:6/14/2019)... ... ... Molecular diagnostics segment is the fastest-growing segment within the global IVD market. The ... are expected to drive the growth are infectious diseases, cancer, and transplant diagnostics. ... The World Molecular Diagnostics Market, 8th Edition . , The discovery of the structure ...
Breaking Biology News(10 mins):
(Date:7/17/2019)... PARK, Md. (PRWEB) , ... July 15, 2019 , ... ... DNA so that a certain trait can be removed, replaced, or edited, but Yiping ... is looking far beyond these traditional applications in his latest publication in Nature Plants. ...
(Date:7/17/2019)... (PRWEB) , ... July 16, ... ... a long-term strategic agreement for the development and manufacturing of Zolgensma® (onasemnogene ... Through this collaboration, AveXis, a Novartis company, will have dedicated manufacturing space ...
(Date:7/17/2019)... ... 2019 , ... Quidel is the market leader in point-of-care ... and Siemens Healthineers and Response Biomedical also are among the top companies. The ... (POC) Diagnostics . , Quidel is a market leader in rapid immunoassays and ...
(Date:7/11/2019)... ... ... At the most recent stem cell training course in Las Vegas ... Heroes Program. The Veterans included individuals and families from all over the US, with ... military Veteran, teacher or first responder to receive a regenerative therapy at a training ...
Breaking Biology Technology:
Cached News: